Clinical Trials Sponsored by Sensome

Total 520 results

Sensome

Not yet recruiting

InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology (INSPECT)

Lung Cancer
Sensome

Recruiting

Impedance Sensor Evaluated in Peripheral Artery Disease for Tissue Detection (SEPARATE)

Peripheral Vascular Disease

Belgium
Sensome

Recruiting

Clotild® Smart Guidewire System (CSGS) Evaluation in EndovascUlar Thrombectomy Procedure (CLOTOUT)

Stroke

Australia, France
Ensoma

Completed

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

Healthy | Renal Insufficiency

United States
Sanome

Withdrawn

Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers

Asthma | COPD | Dyspnea | Shortness of Breath | Asthma Chronic | Wheezing | Breathlessness
Sensimed AG

Withdrawn

TF for the Prediction of Visual Field Progression

Open Angle Glaucoma
Senseye, Inc.

Terminated

Senseye's OBCI Diagnostic Tool for PTSD

PTSD

United States
Sensimed AG

Completed

SENSIMED Triggerfish® in Sitting and Supine Position

Healthy Subjects

Israel
Sensimed AG

Completed

Central Corneal Thickness With SENSIMED Triggerfish (09/08)

Ocular Hypertension | Glaucoma

Germany
Ensoma

Completed

Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor

Healthy Volunteers

United States
Sensimed AG

Completed

Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure

Glaucoma, Open-Angle | Healthy

Poland
Sensimed AG

Completed

IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty

Primary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative Glaucoma

France
Sensimed AG

Completed

SENSIMED Triggerfish Sensor Sizes

Healthy Volunteers

Spain
Sensimed AG

Completed

SENSIMED Triggerfish in Closed Eyes

Glaucoma

Switzerland
Sensimed AG

Completed

Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG

Primary Open Angle Glaucoma | Normal Tension Glaucoma

Poland
Sensimed AG

Completed

24-hour IOP Pattern With SENSIMED Triggerfish® in a Healthy Population

Healthy Subject

Israel
Sensimed AG

Withdrawn

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy

Primary Open Angle Glaucoma

France
Sensimed AG

Withdrawn

IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After LPI

Glaucoma

France
Sensimed AG

Completed

Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor

Primary Open Angle Glaucoma | Healthy Subjects

United States
Sensimed AG

Completed

SENSIMED Triggerfish Safety and Tolerability

Glaucoma

United States
Sensimed AG

Completed

SENSIMED Triggerfish

Glaucoma

Spain, Belgium, Switzerland, Denmark
Sensimed AG

Terminated

Water Drinking Test During Intraocular Pressure Fluctuation (IOP) Monitoring

Healthy Subjects

Switzerland
Sensimed AG

Completed

SENSIMED Triggerfish Discomfort During IOP Monitoring (09/02)

Safety and Tolerability of SENSIMED Triggerfish in Glaucoma Patients

Germany
Senseye, Inc.

Recruiting

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults With PTSD

PTSD | Generalized Anxiety Disorder | Major Depressive Disorder

United States
Sensimed AG

Not yet recruiting

Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry

Ocular Hypertension | Glaucoma

Switzerland
Sensimed AG

Terminated

Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Primary Open-angle Glaucoma (POAG) Patient

United States
Sensimed AG

Completed

IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure

Sleep Apnea, Obstructive | Primary Open-angle Glaucoma

United States
Sensimed AG

Terminated

TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection

Open Angle Glaucoma | Neovascular Age Related Macular Degeneration (AMD)

Spain
Sensimed AG

Completed

An Open Label Study Assessing the 24-hour Intraocular Pressure Pattern in PAC and PACG Patients, Before and After Laser Peripheral Iridotomy

Glaucoma

India
Second Genome

Terminated

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis

United States
Genome & Company

Not yet recruiting

A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Korea, Republic of
Mode Sensors AS

Recruiting

Assessing Hydration Status With a Wearable Bioimpedance Sensor in Elderly Individuals (HELD)

Dehydration

Norway
Sensimed AG
Schlossparkklinik

Completed

24h Continuous Intraocular Pressure (IOP) Monitoring vs Goldmann Applanation Tonometry

Primary Open Angle Glaucoma

Germany
Region Skane
Senzime AB

Completed

Local Metabolism of the Gastric Tube Reconstruction After Esophagectomy

Ischemia | Anastomotic Leakage | Microdialysis

Sweden
Common Sense

Withdrawn

Performance Proof of Product Developed to Detect Abnormal Vaginal pH

Vaginal Infection

Israel
Common Sense

Completed

Pivotal Study of the AL-SENSE in Diagnosis Amniotic Fluid Leakage

AMNIOTIC FLUID LEAKAGE
Common Sense

Unknown

Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery

Preterm Birth | Bacterial Vaginosis | Vaginal Infections | Preterm Premature Rupture of Membranes | Late Miscarriage

Israel
Ensoma
bluebird bio

Terminated

Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease

Sickle Cell Disease

United States
Common Sense

Completed

Pivotal Study of the Rx Al-Sense Liner for Amniotic Fluid Leakage Screening (PRALS)

Amniotic Problems

United States
Common Sense

Unknown

PROOF OF AMNIOSENSE BLUE IN HOME USAGE AND HOSPITAL

Amniotic Problems
Sensimed AG
Yale University

Terminated

IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients

Ocular Hypertension

United States
Sensimed AG
Clinique Monchoisi

Terminated

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy With Collagen Implant

Primary Open Angle Glaucoma

Switzerland
Common Sense

Completed

PERFORMANCE STUDY OF THE AL-SENSE

Amniotic Problems
Common Sense

Unknown

AL-SENSE 1-Step - Determination of Product Specificity (ROM)

PREMATURE RUPTURE OF MEMBRANES

Israel
Human Genome Sciences Inc.

Completed

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Germany, Hungary, Romania
Human Genome Sciences Inc.

Completed

Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic

United States, Canada
Human Genome Sciences Inc.

Completed

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

HIV Infections

United States
Human Genome Sciences Inc.

Completed

Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Recruiting

SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations

Non-small Cell Lung Cancer

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Not yet recruiting

A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor

Advanced Malignant Tumor

China

3

Subscribe